None listed
Conditions
Interventions
Dietary Supplement : - KBL982: twice a day
- Placebo: twice a day
Sponsors
Kobiolabs
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Males and females aged over 19 years, under 75 years at the screening examination 2) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions
Exclusion criteria
Exclusion criteria: 1) Patients with cirrhosis or liver cancer according to abdominal ultrasonography based on visit 2 2) Those who have received chemotherapy or are being treated for malignant tumors other than basal cell carcinoma and squamous cell carcinoma (restrained non-invasive lesions) or those who have been cured of cancer for less than 5 years. 3) In Visit 1, a positive factor for HBs Ag or HCV Ab test. 4) Uncontrolled thyroid disease patients. 5) A person who complains of severe gastrointestinal symptoms such as heartburn and indigestion and has a problem in eating food for human application tests. 6) Those who are sensitive or allergic to food ingredients for this human application test. 7) A person who is pregnant or has plans to become pregnant during the human body application test. 8) Those who participated in other interventional clinical trials (including human application trials) within 1 month of visit 1, or who plan to participate in other interventional clinical trials (including human application trials) after the start of this human application trial. 9) A person who determines that the tester is inappropriate for this human body application test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gamma-Glutamyl Transferase | — |
Secondary
| Measure | Time frame |
|---|---|
| Aspartate Aminotransferase, Alanine Transaminase | — |
Countries
Korea, Republic of
Contacts
Public ContactWoolim Jung
Neonutra
Outcome results
None listed